Navigation Links
Zynx Health Names Mark Long Chief Technology Officer
Date:2/25/2010

e research, design, development and delivery of new and existing applications and the integration of Zynx clinical decision support with leading electronic health record systems. These innovations will serve the global community of Zynx Health clients, representing more than 1,700 hospitals in the United States in addition to a growing global client base. Long will be based in Zynx's Los Angeles office.

Commenting on the appointment, Richard P. Malloch, president, Hearst Business Media, said: "I'm confident that Mark will play an instrumental function in implementing cutting-edge technological initiatives to elevate the role Zynx Health plays in the world of evidence-based health care. He is a game-changing talent!"

Prior to joining Hearst, Long served as the chief technology officer at PortBlue Corporation, where he developed a patented decision support platform that was used for more than 80 software-as-a-service applications, many in the healthcare sector. Previously, Long led technology at PayMyBills.com from an early-stage prototype through processing $1 million a day. PayMyBills, an Idealab company, was an early player in the online banking space and won numerous "Best of Web" awards from Yahoo!, Forbes, Kiplinger and Time Digital.


'/>"/>
SOURCE Hearst Business Media
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
2. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
3. Abbott to Present at Cowen and Company Annual Health Care Conference
4. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
5. Americans Living Longer, Healthier Lives Due to Medical Innovation and New Therapies
6. Guiding Healthcare Leaders Toward Just-in-Time Training
7. New York States Largest Integrated Health System Chooses Craneware Revenue Integrity Solutions
8. Ritter Pharmaceuticals Joins NIH Conference Discussions on Lactose Intolerance and Associated Health Risks
9. Many Americans Enjoying Longer, Healthier Lives Due to Medical Innovation and New Therapies
10. R-Squared Forms Strategic Relationship with IMS Health
11. ISO 9001:2008 Certification Awarded to Health Robotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/5/2015)... 6, 2015 Nihon University is pleased ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up with ... in Tokyo, Japan . Many ... research will present their achievements and future prospects ... industry produced with 8K technology. (Documentation: ...
(Date:7/3/2015)... 4, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... l,intermédiaire de plateformes éducatives gratuites et d,une conférence ... (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) , ... en ligne , Prendre en charge l,hypertension ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3
... 23, 2007 -,Gentium S.p.A. (NASDAQ: GENT) (the ... will be the subject of a poster,presentation ... being held in,Rio de Janeiro, Brazil from ... 2007, Cinara Echart, Ph.D., Manager of,Biological Research ...
... 24 /CNW/ - The weight loss medication Xenical,(orlistat ... such as blood pressure, glycaemic,control and lipid profile ... and hypertension, according to a study analysis,presented at ... ,This analysis strengthens the wealth of data already ...
Cached Medicine Technology:Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 2Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, ... announces the return of its complimentary educational webinar series for the ... leaders creates success for their clients through targeted marketing, sales, digital communications, branding ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... proper reimbursement for radiology services and ADVOCATE is leading the transition. ADVOCATE, the ... coding expertise with their Top 10 Tips for ICD-10. The ten tips are ...
(Date:7/6/2015)... ... , ... Health care systems and genomics projects have generated massive patient data ... use this “Big Data” to improve health and cut costs is now on the ... Sinai Health System in New York City. Physicians will have these new capabilities within ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... received nearly $400,000 in grant funds to support a three-year effort to reduce ... The work will be conducted in partnership with the Morehouse School of Medicine’s ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us ... 29 million Americans have diabetes, the majority of which are Type 2. However, eight ... more than one in three, have prediabetes (abnormally high blood sugar levels). Without reductions ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2
... same breast cancer treatments as Hispanic and white women ... were more likely to be diagnosed// with later-stage cancer ... ,For the study, lead researcher Wendy ... Cancer Center and colleagues examined 2,140 women participating in ...
... weight loss drugs are really safe, an analysis of previous ... was conducted. What// came to light was the lack of ... ,Two Canadian researchers, Raj Padwal and Sumit Majumdar of ... like sibutramine (Meridia), orlistat (Xenical) and rimonabant (Acomplia) are no ...
... near toxic waste may make you diabetic, says a study ... 1993 and 2000.// ,Type-two diabetes has seen a ... from 1980 to 2002. While scientists scramble to find explanations ... the growing diabetes rate. , ,However, the study by ...
... Carolina State University toxologists and Rice University Chemists// has ... intake speed of nanoparticles through the skin. Vitro experiments ... of the research. These bucky balls contained amino acids. ... with the increasing degree of flexing of the skin. ...
... and Prevention (CDC) Atlanta's Division of Tuberculosis Elimination feel ... and made TB tests mandatory for all foreign-born nationals, ... ,Tuberculosis can only be eradicated if all ... necessary, treated for latent TB infection, they say. ...
... Dentists at the Manchester University have developed a new ... x-rays//. This is done by automatically measuring the width ... ,Professor Keith Horner and Dr Hugh Devlin at ... modeling’ technology that was developed by the Division of ...
Cached Medicine News:Health News:Living Near Toxic Waste May Bring On Diabetes 2Health News:Nanoparticle Uptake Zoom by Repetitive Motion 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
Inquire...
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
The computer-optimized optical design produces large, brilliant images of high resolution....
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: